Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.440
-0.110 (-4.31%)
At close: Sep 12, 2025, 4:00 PM EDT
2.460
+0.020 (0.82%)
After-hours: Sep 12, 2025, 4:00 PM EDT

Cyclerion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
8882975104
Upgrade
Market Cap Growth
62.48%-0.51%-71.30%-61.69%-28.31%39.09%
Upgrade
Enterprise Value
55-181684
Upgrade
Last Close Price
2.463.223.3513.1234.4061.20
Upgrade
PS Ratio
3.044.08-96.1018.9045.26
Upgrade
PB Ratio
0.880.920.732.731.541.75
Upgrade
P/TBV Ratio
0.920.920.732.731.541.75
Upgrade
EV/Sales Ratio
2.242.64-27.393.9336.37
Upgrade
Debt / Equity Ratio
-----0.77
Upgrade
Asset Turnover
0.220.17-0.010.050.02
Upgrade
Quick Ratio
4.415.233.631.774.883.22
Upgrade
Current Ratio
5.035.833.851.945.003.45
Upgrade
Return on Equity (ROE)
-22.43%-30.36%-115.85%-62.17%-95.87%-98.97%
Upgrade
Return on Assets (ROA)
-24.15%-19.76%-38.34%-29.94%-38.86%-34.34%
Upgrade
Return on Capital (ROIC)
-27.05%-22.52%-55.47%-39.48%-44.24%-37.44%
Upgrade
Earnings Yield
-24.69%-37.51%-64.25%-154.44%-69.32%-74.87%
Upgrade
FCF Yield
-35.87%-53.17%-259.37%-142.29%-49.02%-71.22%
Upgrade
Buyback Yield / Dilution
-8.63%-7.70%-7.59%-11.03%-28.75%-11.04%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q